“Integrated Network Pharmacology, ADMET Profiling, and Molecular Docking Investigation of Losartan and Its Active Metabolite Against Angiotensin-Related Target” (2026) International Journal of Pharmaceutical Research and Medicinal Plants, 2(5), pp. 76–82. doi:10.61280/4sa10p81.